Interstitial Lung Disease News and Research

RSS
Interstitial lung disease (ILD) is a broad group of lung diseases comprising of more than a hundred distinct disorders. All of these involve scarring or inflammation of the interstitial lung tissue and affect the volume of oxygen that can reach the bloodstream via the respiratory system.
Idiopathic pulmonary fibrosis could soon be diagnosed without the need for surgical lung biopsy

Idiopathic pulmonary fibrosis could soon be diagnosed without the need for surgical lung biopsy

Chest radiography highly predictive of pulmonary hypertension

Chest radiography highly predictive of pulmonary hypertension

Pulmonary Fibrosis Foundation selects UofL for newly established Care Center Network

Pulmonary Fibrosis Foundation selects UofL for newly established Care Center Network

GSK receives FDA approval for combination of Mekinist with Tafinlar for treatment of melanoma

GSK receives FDA approval for combination of Mekinist with Tafinlar for treatment of melanoma

6MWT wording change could enhance serial utility

6MWT wording change could enhance serial utility

New classification criteria for systemic sclerosis published in ACR journal

New classification criteria for systemic sclerosis published in ACR journal

Study confirms exposure to arsenic in drinking water can impair lung function

Study confirms exposure to arsenic in drinking water can impair lung function

ATS releases clinical practice guidelines on management of childhood ILD in infants

ATS releases clinical practice guidelines on management of childhood ILD in infants

Study shows TOLLIP gene variant is linked to increased mortality risk in IPF patients

Study shows TOLLIP gene variant is linked to increased mortality risk in IPF patients

CPF and PFF to partner with ATS to fund pulmonary fibrosis research

CPF and PFF to partner with ATS to fund pulmonary fibrosis research

Computed tomography aids scleroderma lung disease prognosis

Computed tomography aids scleroderma lung disease prognosis

Chronic respiratory disease treatments: an interview with Dr Sven Jan-Anders Karlsson, CEO of Verona Pharma

Chronic respiratory disease treatments: an interview with Dr Sven Jan-Anders Karlsson, CEO of Verona Pharma

Researchers define new treatment for potentially fatal lung disease in patients with CVID

Researchers define new treatment for potentially fatal lung disease in patients with CVID

Springer adds 6 new quarterly clinical review journals to medicine portfolio

Springer adds 6 new quarterly clinical review journals to medicine portfolio

Statin use may influence susceptibility to ILD in smokers

Statin use may influence susceptibility to ILD in smokers

BUSM researcher receives two NIH grants to study scleroderma

BUSM researcher receives two NIH grants to study scleroderma

Blood biomarker panel can predict survival in IPF patients

Blood biomarker panel can predict survival in IPF patients

Simmons Center to evaluate CGEN-25009 for treatment of idiopathic pulmonary fibrosis

Simmons Center to evaluate CGEN-25009 for treatment of idiopathic pulmonary fibrosis

Gastroespophageal reflux treatment might improve survival in patients with IPF

Gastroespophageal reflux treatment might improve survival in patients with IPF

Study confirms link between delayed access to tertiary care for IPF, higher risk of death

Study confirms link between delayed access to tertiary care for IPF, higher risk of death